COVID 19 Diagnostics Market

ID: MRFR/MED/8232-CR
119 Pages
Rahul Gotadki
Last Updated: June 08, 2026
COVID-19 Diagnostics Market Research Report By Test Type (PCR Tests, Antigen Tests, Antibody Tests, CRISPR Tests), By End User (Hospitals, Clinics, Laboratories, Home Care), By Sample Type (Nasopharyngeal Swabs, Oropharyngeal Swabs, Saliva, Serum), By Distribution Channel (Direct Sales, Retail Pharmacies, Online Sales) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Test Type (USD Billion) | |
      1. 4.1.1 PCR Tests | |
      2. 4.1.2 Antigen Tests | |
      3. 4.1.3 Antibody Tests | |
      4. 4.1.4 CRISPR Tests |
    2. 4.2 Healthcare, BY End User (USD Billion) | |
      1. 4.2.1 Hospitals | |
      2. 4.2.2 Clinics | |
      3. 4.2.3 Laboratories | |
      4. 4.2.4 Home Care |
    3. 4.3 Healthcare, BY Sample Type (USD Billion) | |
      1. 4.3.1 Nasopharyngeal Swabs | |
      2. 4.3.2 Oropharyngeal Swabs | |
      3. 4.3.3 Saliva | |
      4. 4.3.4 Serum |
    4. 4.4 Healthcare, BY Distribution Channel (USD Billion) | |
      1. 4.4.1 Direct Sales | |
      2. 4.4.2 Retail Pharmacies | |
      3. 4.4.3 Online Sales |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Abbott Laboratories (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Roche Diagnostics (CH) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Thermo Fisher Scientific (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Siemens Healthineers (DE) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 BD (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Cepheid (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Hologic (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 PerkinElmer (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Bio-Rad Laboratories (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TEST TYPE |
    7. 6.4 US MARKET ANALYSIS BY END USER |
    8. 6.5 US MARKET ANALYSIS BY SAMPLE TYPE |
    9. 6.6 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    10. 6.7 CANADA MARKET ANALYSIS BY TEST TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY END USER |
    12. 6.9 CANADA MARKET ANALYSIS BY SAMPLE TYPE |
    13. 6.10 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY TEST TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY END USER |
    17. 6.14 GERMANY MARKET ANALYSIS BY SAMPLE TYPE |
    18. 6.15 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    19. 6.16 UK MARKET ANALYSIS BY TEST TYPE |
    20. 6.17 UK MARKET ANALYSIS BY END USER |
    21. 6.18 UK MARKET ANALYSIS BY SAMPLE TYPE |
    22. 6.19 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    23. 6.20 FRANCE MARKET ANALYSIS BY TEST TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY END USER |
    25. 6.22 FRANCE MARKET ANALYSIS BY SAMPLE TYPE |
    26. 6.23 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    27. 6.24 RUSSIA MARKET ANALYSIS BY TEST TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY END USER |
    29. 6.26 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE |
    30. 6.27 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    31. 6.28 ITALY MARKET ANALYSIS BY TEST TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY END USER |
    33. 6.30 ITALY MARKET ANALYSIS BY SAMPLE TYPE |
    34. 6.31 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    35. 6.32 SPAIN MARKET ANALYSIS BY TEST TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY END USER |
    37. 6.34 SPAIN MARKET ANALYSIS BY SAMPLE TYPE |
    38. 6.35 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY END USER |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY TEST TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY END USER |
    46. 6.43 CHINA MARKET ANALYSIS BY SAMPLE TYPE |
    47. 6.44 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    48. 6.45 INDIA MARKET ANALYSIS BY TEST TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY END USER |
    50. 6.47 INDIA MARKET ANALYSIS BY SAMPLE TYPE |
    51. 6.48 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    52. 6.49 JAPAN MARKET ANALYSIS BY TEST TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY END USER |
    54. 6.51 JAPAN MARKET ANALYSIS BY SAMPLE TYPE |
    55. 6.52 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY END USER |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY TEST TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY END USER |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    64. 6.61 THAILAND MARKET ANALYSIS BY TEST TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY END USER |
    66. 6.63 THAILAND MARKET ANALYSIS BY SAMPLE TYPE |
    67. 6.64 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    68. 6.65 INDONESIA MARKET ANALYSIS BY TEST TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY END USER |
    70. 6.67 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE |
    71. 6.68 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY TEST TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY END USER |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY TEST TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY END USER |
    79. 6.76 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE |
    80. 6.77 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    81. 6.78 MEXICO MARKET ANALYSIS BY TEST TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY END USER |
    83. 6.80 MEXICO MARKET ANALYSIS BY SAMPLE TYPE |
    84. 6.81 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY TEST TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY END USER |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY END USER |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY END USER |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY TEST TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY END USER |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY END USER, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY SAMPLE TYPE, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Test Type (USD Billion, 2025-2035)

  • PCR Tests
  • Antigen Tests
  • Antibody Tests
  • CRISPR Tests

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Clinics
  • Laboratories
  • Home Care

Healthcare By Sample Type (USD Billion, 2025-2035)

  • Nasopharyngeal Swabs
  • Oropharyngeal Swabs
  • Saliva
  • Serum

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Direct Sales
  • Retail Pharmacies
  • Online Sales